Akrimax Pharmaceuticals Appoints Neil Larimer as Vice President Business Development & Manufacturing Alliances
May 05, 2010 – Cranford, NJAkrimax Pharmaceuticals, LLC announced today that Neil Larimer has joined the company as Vice President Business Development & Manufacturing Alliances. His responsibilities will include strategic marketing and major contract development for products to be manufactured at Akrimax’s Rouses Point, New York facility. Akrimax acquired the former Wyeth Pharmaceuticals Rouses Point plant in January 2008.
Mr. Larimer has twenty years of combined management, sales, marketing and operations experience in the pharmaceutical industry. Most recently, Mr. Larimer served as Senior Director, North America - Sales & Marketing at DPT Laboratories. While at DPT, he successfully led numerous development and manufacturing programs for various pharmaceutical companies.
“We are extremely pleased to have Neil join our executive management team. Neil is a proven professional in building long term client relationships and will contribute in the further development of our Rouses Point facility as a world class pharmaceutical manufacturing operation,” said Alan L. Rubino, CEO and President of Akrimax.
Prior to joining DPT Laboratories in 2001, Mr. Larimer has held senior positions at Owens & Minor, National Labnet and Baxter/VWR Scientific Products. Mr. Larimer is a Bachelor of Science, General Engineering graduate of the U.S. Naval Academy and holds a MBA from Brenau University.
About Akrimax
Akrimax Pharmaceuticals, LLC is a privately-held, fully-integrated next-generation specialty pharmaceutical company that acquires, markets and develops products to
address disease states related to metabolic diseases. The company also owns a world-class manufacturing plant in Rouses Point, NY with a highly skilled workforce.
The plant encompasses 67.6 acres with 38 buildings, offering approximately 1 million sq. feet of manufacturing and packaging space. Akrimax was formed in 2007 and
purchased the Rouses Point plant from Wyeth in January 2008.
Based in Cranford, NJ, Akrimax pursues unsurpassed quality in the development, production, manufacturing, distribution, and commercialization of a full range of top-quality pharmaceutical products.
For more information:
www.Akrimax.com
Timothy Soule: tsoule@akrimax.com
